By IANS,
Chennai : With fresh funding of $11 million, city based medical equipment company Perfint Healthcare Pvt Ltd says it plans to commercialise its latest machine, expand its research and development (R&D) activity in the US and enter markets like the US, China and Japan.
Speaking to reporters here Thursday, compnay CEO S. Nandakumar said: “We have received $11 million from Norwest Venture Partners last week. We will be using the money to commercialise our new product Maxio; develop ultrasound guided procedure and tissue characterization, get regulatory approvals in US, China and Japan and also expand advanced technology lab in the US.”
The company’s latest equipment Maxio helps in non-invasive treatment of cancer. It is an integrated visualization, planning and robotic targeting system for computed tomography (CT) guided tumor ablations (removal of tissue).
According to Nandakumar, the company will be closing this fiscal, selling around 200 units of Robio and Maxio.
“We hope to close this fiscal with a turnover of $10 million and target $50 million revenue by 2016. The company would turn profitable next fiscal,” he said.
In the domestic market, Perfint sells directly while in the overseas markets, sales are through distributors.
“We are looking at outright sale now. May be in the future we may look at other models like pay-per-use,” said Nandakumar.
Queried about the competition, he said the medical equipment majors are slowly getting into this segment as their earlier focus was on imaging products.